All-trans retinoic acid decreases susceptibility of a gastric cancer cell line to lymphokine-activated killer cytotoxicity

British Journal of Cancer

Volumn 75, Issue 9, 1997, Pages 1284-1290

  Chao, T Y ^a   Jiang, S Y ^a   Shyu, R Y ^a   Yeh, M Y ^a   Chu, T M ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

All trans retinoic acid; Gastric cancer cell line; Lymphokine activated killer cells

Indexed keywords

CYCLIN A; CYCLIN B; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL STRAIN HL 60; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; PRIORITY JOURNAL;

EID: 0030970203     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.218     Document Type: Article

References (41)

1. Albertini MR, Gibson DF, Robinson SP, Howard SP, Tans KJ, Lindstrom MJ, Robinson RR, Tormey DC, Jordan VC and Sondel PM (1992) Influence of estradiol and tamoxifen on susceptibility of human breast cancer cell lines to lysis by lymphokine-activated killer cells. J Immunother 11: 30-39
2. Apasov S, Redegeld F and Sitkovsky M (1993) Cell-mediated cytotoxicity: contact and secreted factors. Curr Opin Immunol 5: 404-410
3. Athanassiades T (1981) Adjuvant effect of vitamin A palmiate and analogs on cell-mediated immunity. J Natl Cancer Inst 67: 1153-1156
4. Bollag W and Peck R (1993) Modulation of growth and differentiation by combined retinoids and cytokines in cancer. In Retinoids in Oncology, Hong WK and Lotan R (eds), pp. 89-108. Marcel Dekker:New York
5. Bouillon M and Audette M (1994) Retinoic acid-stimulated intercellular adhesion molecule-1 expression on SK-N-SH cells: calcium/calmodulin-dependent pathway. Cancer Res 54: 4144-4149
6. Butler WB and Fontana JA (1992) Responses to retinoic acid of tamoxifen-sensitive and -resistant subline of human breast cancer cell line MCF-7. Cancer Res 52: 6164-6167
7. Chao TY, Ohnishi H and Chu TM (1991)) Indirect inhibition of generation of murine lymphokine-activated killer cell activity in splenocyte cultures by interferon-gamma. Immunology 70: 116-120
8. Chao TY, Ting CS, Yeh MY, Chang JY, Wang CC and Chu TM (1995a) Effects of indomethacin on lymphokine-activated killer cell activities in cancer patients. Tumor Biol 16: 230-242
9. Chao TY, Huang WS and Yeh MY (1995b) Generation of lymphokine-activated killer (LAK) cell activity from malignant peritoneal effusions. Proc Natl Sci Council ROC Part B 19: 92-98
10. 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines. Cancer Res 55: 2380-2386
11. Cordon-Cardo C (1995) Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am J Pathol 147: 545-560
12. Correale P, Procopio A, Celio L, Caraglia M, Cenua G, Coppola V, Pepe S, Normanno N, Vecchio I, Palmieri G, Montagnani S, Tagliaferri P and Bianco AR (1992) Phorbol 12-myristate 13-acetate induces resistance of human melanoma cell to natural-killer- and lymphokine-activated-killer-mediated cytotoxicity. Cancer Immunol Immunother 34: 272-278
13. De Fries RU und Golub SH (1988) Characteristics and mechanisms of IFN-γ induced protection of human tumor cells from lysis by lymphokine-activated killer cells. J Immunol 140: 3686-3693
14. Degos L (1992) Retinoic acid in acute promyelocytic leukemia: a model for differentiation therapy. Curr Opin Oncol 4: 45-52
15. Dillehay D, Walia A and Lamon E (1988) Effects of retinoids on macrophage function and IL-1 activity. J Leuk Biol 44: 353-360
16. Dmitrovsky E, Markman M and Marks PA (1990) Clinical use of differentiating agents in cancer therapy. In Cancer Chemotherapy and Biologic Response Modifiers Annual II, Pinedo HM, Chabner GA and Longo DL (eds), pp. 303-320. Elsevier: Amsterdam
17. Fady C, Gardner A, Gera JF and Lichtenstein A (1993) Interferon-γ-induced increased sensitivity of HER2/neu-overexpressing tumor cells to lymphokine-activated killer cell lysis: importance of ICAM-1 in binding and post-binding events. Cancer Immunol Immunother 37: 329-336
18. Fegan C, Bailey-Wood R, Coleman S, Phillips SA, Neale L, Hoy T and Whittaker JA (1995) All trans retinoic acid enhances human LAK activity. Eur J Hematol 54: 95-100
19. Foreman NK, Rill DR, Coustan-Smith E, Douglass EC and Brenner MK (1993) Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine-activated killer cells. Potential for residual disease eradication. Br J Cancer 67: 933-938
20. Galandrini R, Albi N, Zarcone D, Grossi CE and Velardi A (1992) Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity. Eur J Immunol 22: 2047-2053
21. Henkart PA (1994) Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1: 343-346
22. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ and Wang ZY (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567-572
23. Katsanis E, Bausero MA, Xu H, Orchard PJ, Xu Z, Mcivor RS, Brian AA and Blazar BR (1994) Transfection of the mouse ICAM-1 gene into murine neuroblastoma enhances susceptibility to lysis, reduced in vivo tumorigenicity and decreases ICAM-2-dependent killing. Cancer Immunol Immunother 38: 135-141
24. Lin TH and Chu TM (1990) Enhancement of murine lymphokine-activated killer cell activity by retinoic acid. Cancer Res 50: 3013-3018
25. Lotan R, Lotan D and Sacks PG (1990) Inhibition of tumour cell growth by retinoids. Methods Enzymol 190: 100-110
26. Love JM and Gudas LJ (1994) Vitamin A, differentiation and cancer. Curr Opin Cell Biol 6: 825-831
27. Martin S, Bradley J and Cotter T (1990) HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exp Immunol 79: 448-453
28. Nano R, Barni S, Capelli E, Prosperi E, Lavezzi L and Salvucci O (1995) DNA-protein cell content of lymphokine-activated killer (LAK) and target cells in coculture. Anticancer Res 15: 751-754
29. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S and Hammar S (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334: 1105-1155
30. Palumbo A, Battaglio S, Napoli P, Bruno H, Omede P, Boccadoro M and Pileri A (1995) Retinoic acid inhibits the growth of human myeloma cells in vitro. Br J Hematol 89: 555-560
31. Robertson MJ, Caligiuri MA, Manley TJ, Levine H and Ritz J (1990) Human natural killer cell adhesion molecule's. Differential expression after activation and participation in cytolysis. J Immunol 145: 3194-3201
32. Shyu RY, Jiang SY, Huang SL, Chang TC, Wu KL, Roffler SR and Yeh MY (1995) Growth retardation by all-trans-retinoic acid and retinoic acid receptor messenger ribonucleic acids expression in gastric cancer cells. Eur J Cancer 31A: 237-243
33. Smith MA, Parkinson DR, Cheson BD and Friedman MA (1992) Retinoids in cancer therapy. J Clin Oncol 10: 839-864
34. Strickland S and Sawey MJ (1980) Studies on the effect of retinoids on the differentiation of teratocarcinoma stem cells in vitro and in vivo. Dev Biol 78: 76-85
35. Teichmann JV, Ludwig WD and Thiel E (1992) GM-CSF-mediated proliferation induction improves the susceptibility of leukemia cells to lymphokine-activated killer cells. Int J Hematol 55: 255-264
36. Triozzi PL, Eicher DM, Smoot J and Rinehart JJ (1992) Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1. Exp Hematol 20: 1072-1076
37. Villa ML, Ferrario E, Trabattoni D, De Palo G, Magni A, Veronesi U and Clerici E (1993) Retinoids, breast cancer and NK cells. Br J Cancer 68: 845-850
38. Warrell RP Jr, Frankel SR, Miller JR, WH, Scheinberg DA, Itri LM, Hittelman WN, Vyas R, Andreeff M, Tafuri A, Jakubowski A, Gabrilove J, Gordon MS and Dmitrovsky E (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324: 1385-1393
39. Warrell RP Jr, De The H, Wang ZY and Degos L (1993) Acute promyelocytic leukemia. N Engl J Med 329: 177-189
40. Zou CP, Clifford JL, Xu XC, Sacks PG, Chambon P, Hong WK and Lotan R (1994) Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines. Cancer Res 54: 5479-5487
41. Zychlinsky A, Zheng LM, Liu C-Y and Young JD-E (1991) Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J Immunol 146: 393-400